Abstract
This research service give a detailed analysis of the European hGH market from
2007 to 2014. The effect of various drivers and challenges for the hGH market
are discussed and revenue forecasts provided based on market dynamics.
Reimbursements issues and approval processes are described. Revenue forecasts
include revenues by each country in Europe. Strategic recommendations are
provided for the various challenges facing LIMS vendors in the European market.